OptimizeRx (OPRX) Financial Statements & Analysis

OptimizeRx (OPRX) Income Statement

OptimizeRx reported revenue of $109.43M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 18.8% from $92.13M a year earlier. Net income was $5.13M, a net margin of 4.7%. Gross margin was 67.3% and operating margin 10.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $20.50M, down 29.8% from the same quarter a year earlier.

OptimizeRx Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

OptimizeRx Corporation income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	109.43	92.13	71.52	71.52	62.45	61.29	43.31	24.60	21.21	12.13
Cost of Revenue	35.83	32.75	28.62	28.62	23.48	25.65	19.21	9.16	9.00	6.17
Gross Profit	73.60	59.38	42.90	42.90	38.97	35.64	24.11	15.44	12.21	5.95
Operating Expenses
Research & Development	0.00	0.00	0.00	-	0.00	0.00	0.00	1.60	0.68	1.01
Selling, General & Administrative	50.25	49.56	58.02	40.03	49.24	33.19	20.18	14.36	10.29	6.75
Operating Expenses	61.90	73.08	69.30	69.30	51.26	35.28	25.43	19.13	12.03	8.08
Operating Income	11.69	-13.71	-26.40	-26.40	-12.29	0.36	-1.32	-3.69	0.18	-2.13
Other Income/Expense
Interest Income	0.35	0.33	2.19	2.19	0.85	0.02	0.07	0.29	0.05	0.03
Interest Expense	5.29	-6.16	1.45	-1.45	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-4.74	-5.68	1.24	1.24	0.85	0.02	-0.07	1.45	0.05	0.03
Income
Income Before Tax	6.95	-19.39	-25.16	-25.16	-11.44	0.38	-2.21	-2.24	0.23	-2.10
Income Tax Expense	-1.82	-0.73	-7.60	7.60	0.00	0.00	0.00	0.90	0.00	0.00
Net Income	5.13	-20.11	-17.57	-17.57	-11.44	0.38	-2.21	-3.14	0.23	-2.10
Net Income - Continuous Operations	5.13	-20.11	-17.57	-17.57	-11.44	0.38	-2.21	-3.14	0.23	-2.10
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	16.39	-1.65	-21.31	-10.85	-9.42	2.34	0.65	-1.51	1.24	-1.81
EBIT	12.06	-5.97	-	-13.25	-11.44	0.36	-1.32	-	-	-
Depreciation & Amortization	4.33	4.33	2.40	2.40	2.02	1.97	1.97	1.18	0.32	0.32
Earnings Per Share
Basic EPS	-	-1.00	-1.00	-1.00	-1.00	-	-	-	-	-
Diluted EPS	-	-1.00	-1.00	-1.00	-1.00	-	-	-	-	-
Basic Shares Outstanding	18.56	18.29	17.12	17.12	17.78	17.23	14.83	13.39	11.32	9.82
Diluted Shares Outstanding	19.00	18.29	17.12	17.12	17.78	17.69	14.83	13.39	11.86	9.82

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About OptimizeRx Financial Statements

What was OptimizeRx's revenue in fiscal 2025?

OptimizeRx reported revenue of $109.43M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 18.8% from $92.13M a year earlier.

Is OptimizeRx profitable?

Yes. OptimizeRx earned net income of $5.13M in fiscal 2025, a net margin of 4.7%. In fiscal 2024 it lost $20.11M.

What is OptimizeRx's operating margin?

OptimizeRx's operating income was $11.69M on revenue of $109.43M in fiscal 2025, an operating margin of 10.7%, compared with -14.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition